Pain is much more than nociception. It is influenced by a number of psychological and social factors; therefore, it is imperative that physical, functional, and psychosocial assessment tools are used when evaluating pain, whether in person or conducted remotely via Telehealth. These tools include the GAD-7, PHQ-9, pain catastrophizing and opioid risk tools, unimodal pain scales, as well as common pain intensity scales such as the Numeric Rating Scale (NRS), Verbal Descriptor Scale (VDS), and Faces Pain Scale-Revised (FPS-R). It is vital that clinicians are equipped with strategies and best approaches to administering these tools throughout the current COVID-19 pandemic.
Case-based learning is helpful in illustrating not just strategies for managing challenging patients, but also in sharing experiences and insights on maintaining quality care when facing changes in clinical workflow. To help clinicians adapt to virtual appointments, this CME Outfitters BriefCase features expert faculty presenting a case vignette that demonstrates tips for performing psychosocial and physical assessments via a telehealth appointment in order to educate clinicians on appropriate management of pain and the viability of Telehealth for pain evaluation and ongoing management.
At the end of this CME/CE activity, participants should be able to apply knowledge of acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.
The following learning objectives pertain only to those requesting CNE or CPE credit: Describe acute and chronic pain pathways and underlying mechanisms to clinical assessment and appropriate management of pain.
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).
Physicians, dentists, PAs, NPs, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Stanos reports that he is a consultant for Pfizer Inc.; Salix Pharmaceuticals; Sanofi; and SCILEX Pharmaceuticals, Inc.
Tony Graham, MD (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-109-H08-P.
Call us at 877.CME.PROS (877.263.7767).